Your session is about to expire
← Back to Search
Formoterol Fumarate for Type 2 Diabetes and Obesity (GB10 Trial)
GB10 Trial Summary
This trial is testing if a drug called formoterol fumarate can help people with obesity and Type 2 diabetes by activating their brown adipose tissue.
- Obesity
- Type 2 Diabetes
GB10 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGB10 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GB10 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You smoke or drink more than two alcoholic beverages per day.You have a long-term medical condition that requires medication.You cannot have taken any medication other than acetaminophen or non-steroidal anti-inflammatory drugs without decongestants or stimulants, within a short period of time.You are taking any medication regularly, except for birth control pills.You have had an allergic reaction or intolerance to lactose, formoterol, nicotinic acid, or local anesthesia in the past.Your body mass index (BMI) falls between 18 and 30 kg/m2.You have gained or lost more than 2 kilograms of weight in the last three months, or made significant changes to your lifestyle.
- Group 1: Acute Cold Exposure
- Group 2: Formoterol with nicotinic acid
- Group 3: Formoterol without nicotinic acid
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor open to participants who are at least eighteen years old?
"In this medical trial, candidates must be of age (18+) yet younger than 45."
What is the upper limit of individuals who can participate in this experiment?
"Affirmative. According to the information uploaded on clinicaltrials.gov, this medical trial opened for enrolment in July 2022 and was recently updated on September 22nd of that same year. The investigation is currently looking for 16 individuals from a single centre."
Are my qualifications sufficient for inclusion in this experiment?
"This study seeks 16 individuals with obesity to take part, aged between 18 and 45. Applicants must meet the standard Body Mass Index range of 18-30 kg/m2."
Are there any opportunities for patients to take part in this experiment?
"Affirmative. Per the clinicaltrials.gov records, this medical trial is actively accepting participants since it was first posted on July 5th 2022 and recently updated on September 22nd 2022. A total of 16 patients are needed for enrollment at a single site."
Share this study with friends
Copy Link
Messenger